T vs. TGTX
T (AT&T Inc.) and TGTX (TG Therapeutics, Inc.) are both stocks. T operates in Telecom Services (Communication Services), while TGTX operates in Biotechnology (Healthcare). Over the past 10 years, T returned 3.11%/yr vs 22.01%/yr for TGTX. At a 0.11 correlation, their price movements are largely independent.
Performance
T vs. TGTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, T achieves a -4.15% return, which is significantly lower than TGTX's 68.74% return. Over the past 10 years, T has underperformed TGTX with an annualized return of 3.11%, while TGTX has yielded a comparatively higher 22.01% annualized return.
T
- 1D
- -1.23%
- 1M
- -3.08%
- YTD
- -4.15%
- 6M
- -2.06%
- 1Y
- -13.78%
- 3Y*
- 19.48%
- 5Y*
- 7.30%
- 10Y*
- 3.11%
TGTX
- 1D
- 1.58%
- 1M
- 27.34%
- YTD
- 68.74%
- 6M
- 60.14%
- 1Y
- 39.68%
- 3Y*
- 25.14%
- 5Y*
- 6.51%
- 10Y*
- 22.01%
T vs. TGTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
T AT&T Inc. | -4.15% | 13.97% | 44.08% | -2.74% | 5.76% | -8.09% | -21.37% | 45.55% | -22.25% | -4.01% |
TGTX TG Therapeutics, Inc. | 68.74% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
Correlation
The correlation between T and TGTX is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since May 3, 2010 | 0.11 |
The correlation between T and TGTX shifts across timeframes, from 0.05 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
T:
$3.04
TGTX:
$2.87
T:
7.65
TGTX:
17.51
T:
0.32
TGTX:
0.03
T:
1.33
TGTX:
11.55
T:
$125.65B
TGTX:
$700.35M
T:
$105.41B
TGTX:
$581.54M
T:
$54.70B
TGTX:
$156.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
T vs. TGTX — Risk / Return Rank
T
TGTX
T vs. TGTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AT&T Inc. (T) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| T | TGTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.47 | ||
| Sortino ratioReturn per unit of downside risk | -2.25 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.19 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | 1.22 | -1.85 |
| Martin ratioReturn relative to average drawdown | -1.29 | 2.21 | -3.50 |
Loading charts...
Drawdowns
T vs. TGTX - Drawdown Comparison
The maximum T drawdown since its inception was -64.15%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for T and TGTX.
Loading charts...
Drawdown Indicators
| T | TGTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.15% | -99.52% | +35.37% |
Max Drawdown (1Y)Largest decline over 1 year | -21.87% | -32.66% | +10.79% |
Max Drawdown (3Y)Largest decline over 3 years | -21.87% | -74.79% | +52.92% |
Max Drawdown (5Y)Largest decline over 5 years | -32.01% | -90.75% | +58.74% |
Max Drawdown (10Y)Largest decline over 10 years | -42.35% | -93.19% | +50.84% |
Current DrawdownCurrent decline from peak | -19.13% | -78.45% | +59.32% |
Average DrawdownAverage peak-to-trough decline | -15.72% | -91.42% | +75.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.70% | 18.03% | -7.33% |
Volatility
T vs. TGTX - Volatility Comparison
The current volatility for AT&T Inc. (T) is 8.27%, while TG Therapeutics, Inc. (TGTX) has a volatility of 14.69%. This indicates that T experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| T | TGTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.27% | 14.69% | -6.42% |
Volatility (6M)Calculated over the trailing 6-month period | 17.84% | 34.05% | -16.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.21% | 47.11% | -24.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.03% | 87.80% | -63.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.74% | 86.90% | -63.16% |
Dividends
T vs. TGTX - Dividend Comparison
T's dividend yield for the trailing twelve months is around 4.77%, while TGTX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
T AT&T Inc. | 4.77% | 4.47% | 4.87% | 6.62% | 6.66% | 8.46% | 7.23% | 5.22% | 7.01% | 5.04% | 4.51% | 5.46% |
TGTX TG Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
T vs. TGTX - Financials Comparison
This section allows you to compare key financial metrics between AT&T Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
T and TGTX have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TGTX has higher volatility (14.69%) compared to T (8.27%). In terms of maximum drawdown, T dropped -64.15% vs TGTX's -99.52%.
TGTX currently has the higher Sharpe Ratio (0.85 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for T and TGTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer